FRONTEO's fall prediction AI system "Coroban" introduced at St. Marianna University School of Medicine Hospital

Home » corporate » News » 2022 » FRONTEO's fall prediction AI system "Coroban" introduced at St. Marianna University School of Medicine Hospital
2022.03.24 Press release

--To the press -

FRONTEO's fall prediction AI system "Coroban" introduced at St. Marianna University School of Medicine Hospital

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) has a fall prediction AI system "Coroban" provided by FRONTEO, which is a school corporation of St. Marianna University School of Medicine (Location: Kawasaki, Kanagawa Prefecture). We are pleased to inform you that it was introduced at St. Marianna University School of Medicine Hospital (location: same, hospital director: Taketo Otsubo) of the city, director: Katsuya Akashi).

 

 

 Coroban utilizes the natural language processing AI engine "Concept Encoder (trademark: conceptencoder, reading: concept encoder)" originally developed by FRONTEO to predict the risk of falling from the nursing records written in the electronic medical record and display an alert. It is a system to do. Development began in 2016, and sales to medical institutions began in 2019 with Eisai Co., Ltd., and it is currently being introduced at medical institutions. Obtained a patent in January 2020 (patent registration number: Patent No. 1), and in March of the same year, it was certified as a recommended product by the Japan Society for Fall Prevention.

 


AI analyzes nursing records written in electronic medical records and evaluates the risk of falls

 

 FRONTEO will contribute to solving medical problems in Japan, reducing the burden on medical sites, and improving the QOL of patients through research and development of safe and practical medical devices and software that utilize AI.

 


■ About Coroban
 URL:https://lifescience.fronteo.com/aidevice/coroban/
Coroban is a fall prediction system using the artificial intelligence Concept Encoder developed by FRONTEO in collaboration with Eisai Inc. The Concept Encoder reads the electronic medical record and evaluates the risk of falls from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall risk assessment sheet without increasing the burden on medical staff.Patent registration number: Patent No. 6652986
* This system is not a medical device.This system predicts the risk of falls and is not intended for the judgment of doctors and nurses.

■ About Concept Encoder URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder", and "Looca Cross" that specialize in natural language processing to extract meaningful and important information from a huge amount of text data, and is a company. It is a data analysis company that supports the business of. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.
* Coroban is a registered trademark of Eisai Co., Ltd. and FRONTEO.

 

<Contact information for the press>

PR Department, FRONTEO, Inc.

Email: pr_contact@fronteo.com

 

Inquiries concerning Life Science AI Business

Life Science AI Business Department, FRONTEO, Inc.

https://lifescience.fronteo.com/contact